Metastatic Malignant Neoplasm to the Leptomeninges Withdrawn Phase Trials for Methotrexate (DB00563)

Also known as: Leptomeningeal Metastasis / Neoplastic Meningitis / Leptomeningeal Metastases / Metastatic Malignant Neoplasm in the Leptomeninges / Leptomeningeal Disease (LMD) / Leptomeningeal Disease / Lymphomatous meningitis / Leptomeningeal Carcinomatosis / Metastatic malignant neoplasm to leptomeninges (disorder) / Lymphomatous meningitis (disorder) / Malignant meningitis (disorder) / Leptomeningeal Neoplasms / Meningeal dissemination / Metastases to meninges / Meningeal Carcinomatosis

DBCOND0057483 (Metastatic Malignant Neoplasm to the Leptomeninges)WithdrawnNot Available IdentifierTitlePurposeDrugs
NCT01438021Continuous Intraventricular Methotrexate in Treating Patients With Leptomeningeal DiseaseTreatment